BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4871473)

  • 21. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.
    Hirsch SR; Gaind R; Rohde PD; Stevens BC; Wing JK
    Br Med J; 1973 Mar; 1(5854):633-7. PubMed ID: 4571196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting phenothiazine preparations in the treatment of schizophrenia.
    Kernohan GA
    Br J Psychiatry; 1972 Jan; 120(554):126-7. PubMed ID: 5041515
    [No Abstract]   [Full Text] [Related]  

  • 23. Why a long-acting neuroleptic? Fluphenazine decanoate. (Brief review and clinical rationale).
    Grozier ML
    Psychosomatics; 1971; 12(1):56-60. PubMed ID: 5545629
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.
    Stevens BC
    Psychol Med; 1973 May; 3(2):141-58. PubMed ID: 4577254
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-acting phenothiazine (fluphenazine decanoate) treatment of psychosis.
    Keskiner A; Simeon J; Fink M; Itil TM
    Arch Gen Psychiatry; 1968 Apr; 18(4):477-81. PubMed ID: 4868796
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient maintenance of chronic schizophrenics with long-acting fluphenazine.
    Daniel GR; Schiff AA
    Br Med J; 1973 Apr; 2(5860):244. PubMed ID: 4573207
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and work performance variables in phenothiazine therapy of schizophrenia.
    Chacon C; Harper P
    Acta Psychiatr Scand; 1973; 49(1):65-76. PubMed ID: 4572169
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J; Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A; Quitkin F; Kane J; Klein DF
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of psychiatric management of schizophrenia with fluphenazine decanoate.
    Grosser HH
    Dis Nerv Syst; 1970 Sep; 31():Suppl:32-6. PubMed ID: 4920312
    [No Abstract]   [Full Text] [Related]  

  • 36. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluphenazine enantha--a long-acting phenothiazine.
    Med Lett Drugs Ther; 1969 Jan; 11(1):4. PubMed ID: 4911979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.